Søren Maor Sinay
Chief Operating Officer chez Venus Concept Canada Corp.
Profil
Søren Maor Sinay is the founder of NeoAsia Medical Group.
He is currently the Chief Operating Officer at Venus Concept USA, Inc. and Venus Concept Canada Corp.
Previously, he worked as a Sales Director at UltraShape Ltd., Operations Director at Technicalbiomed Co., Ltd., Vice President-Sales & Marketing at PerfAction Technologies Ltd., and Chief Operating Officer at Venus Concept Ltd.
He also holds an undergraduate degree from Tel-Aviv University and an MBA from Coller School of Management.
Postes actifs de Søren Maor Sinay
| Sociétés | Poste | Début |
|---|---|---|
Venus Concept Canada Corp.
 Venus Concept Canada Corp. Medical SpecialtiesHealth Technology Venus Concept Canada Corp. provides medical and aesthetic technology equipment. The company is headquartered in Toronto, Canada. | Chief Operating Officer | - |
Venus Concept USA, Inc.
 Venus Concept USA, Inc. Medical SpecialtiesHealth Technology Venus Concept USA, Inc. provides non-surgical aesthetic equipment to physicians and clinics for body contouring, skin tightening, and cellulite reduction. The company is headquartered in Weston, FL. | Chief Operating Officer | - |
Anciens postes connus de Søren Maor Sinay
| Sociétés | Poste | Fin |
|---|---|---|
| VENUS CONCEPT INC. | Chief Operating Officer | 06/02/2023 |
Venus Concept Ltd.
 Venus Concept Ltd. Medical SpecialtiesHealth Technology Venus Concept Ltd. provides procedural medical devices for aesthetic procedures. The firm specializes in advanced non-surgical platforms for body contouring, skin tightening, cellulite and scar reduction, skin resurfacing, skin rejuvenation, acne reduction, and hair removal. The company was founded by Domenic Serafino, Oded Ron-Edoute, and Orit Fishgold Ron-Edoute and is headquartered in Toronto, Canada. | Chief Operating Officer | 01/11/2019 |
Technicalbiomed Co., Ltd.
 Technicalbiomed Co., Ltd. Medical DistributorsDistribution Services Technicalbiomed Co., Ltd. supplies medical equipment. The private company is based in Bangkok, Thailand. | Chief Operating Officer | 01/01/2015 |
UltraShape Ltd.
 UltraShape Ltd. Medical SpecialtiesHealth Technology UltraShape redefines aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for fat cell destruction and body sculpting. The company develops and markets clinically proven safe and effective solutions that enhance the lives of patients. The UltraShape proprietary technology employs pulsed (non-thermal) focused ultrasound that instantly, selectively and permanently destroys fat cells without affecting surrounding structures. Founded in 2000, UltraShape has sold Contour I devices in more than 50 countries, demonstrating safety and efficacy. The UltraShape Contour I system, is authorized for marketing outside the U.S. It is the first clinically proven non-invasive solution that offers measurable lasting body sculpting results for men and women with no need for maintenance treatments. The UltraShape system has been shown to be safe and effective in a multi-center controlled trial and numerous other peer-reviewed published independent clinical studies. The device is designed to produce mechanical, non-thermal, acoustic effects which target and selectively destroy (breakdown) fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The latest Contour I V3 system uses Vertical Dynamic Focus™ (VDF) pulsed (non-thermal) focused ultrasound that instantly and permanently destroys fat cells providing patients a convenient noninvasive no-downtime solution to reduce localized fat deposits and body circumference. The UltraShape procedure is based on a natural fat clearance process where triglycerides and cell debris from the destroyed fat cells are processed by the body's natural physiological and metabolic pathways. These pathways are the same that handle fat during weight loss. Results from UltraShape's peer-reviewed published multi-center controlled clinical trial and other independent clinical studies show that the released triglycerides do not accumulate to a clinically significant extent in the blood or liver. Over 200,000 patient treatments have been performed worldwide with the Contour I showing high patient satisfaction while demonstrating safety and efficacy. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guides the operator through a pres-determined treatment algorithm designed to minimize risk of contour irregularities, a common side effect of invasive and non-invasive procedures. The UltraShape procedure is performed during a convenient, 'walk-in, walk-out' session carried out in an office-based environment; it requires no anesthesia or sedation. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The Contour I system is not available for sale in the U.S; the Contour Plus system is an investigational product limited by U.S. law to investigational use only. | Sales & Marketing | - |
PerfAction Technologies Ltd.
 PerfAction Technologies Ltd. Medical SpecialtiesHealth Technology PerfAction Technologies Ltd. develops cutting edge, nonsurgical dermal remodeling technologies for the global medical-aesthetic industry. The company serves patients with aging skin. PerfAction Technologies was founded by Yacha Sutton, Zion Ezer and Pinchas Shalev, Gleb Zilberstein, Shmuel Bukshpan and Eyal Baror in 2007 and is headquartered in Rehovot, Israel. | Sales & Marketing | - |
Formation de Søren Maor Sinay
| Tel-Aviv University | Undergraduate Degree |
| Coller School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VENUS CONCEPT INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
PerfAction Technologies Ltd.
PerfAction Technologies Ltd. Medical SpecialtiesHealth Technology PerfAction Technologies Ltd. develops cutting edge, nonsurgical dermal remodeling technologies for the global medical-aesthetic industry. The company serves patients with aging skin. PerfAction Technologies was founded by Yacha Sutton, Zion Ezer and Pinchas Shalev, Gleb Zilberstein, Shmuel Bukshpan and Eyal Baror in 2007 and is headquartered in Rehovot, Israel. | Health Technology |
UltraShape Ltd.
UltraShape Ltd. Medical SpecialtiesHealth Technology UltraShape redefines aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for fat cell destruction and body sculpting. The company develops and markets clinically proven safe and effective solutions that enhance the lives of patients. The UltraShape proprietary technology employs pulsed (non-thermal) focused ultrasound that instantly, selectively and permanently destroys fat cells without affecting surrounding structures. Founded in 2000, UltraShape has sold Contour I devices in more than 50 countries, demonstrating safety and efficacy. The UltraShape Contour I system, is authorized for marketing outside the U.S. It is the first clinically proven non-invasive solution that offers measurable lasting body sculpting results for men and women with no need for maintenance treatments. The UltraShape system has been shown to be safe and effective in a multi-center controlled trial and numerous other peer-reviewed published independent clinical studies. The device is designed to produce mechanical, non-thermal, acoustic effects which target and selectively destroy (breakdown) fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The latest Contour I V3 system uses Vertical Dynamic Focus™ (VDF) pulsed (non-thermal) focused ultrasound that instantly and permanently destroys fat cells providing patients a convenient noninvasive no-downtime solution to reduce localized fat deposits and body circumference. The UltraShape procedure is based on a natural fat clearance process where triglycerides and cell debris from the destroyed fat cells are processed by the body's natural physiological and metabolic pathways. These pathways are the same that handle fat during weight loss. Results from UltraShape's peer-reviewed published multi-center controlled clinical trial and other independent clinical studies show that the released triglycerides do not accumulate to a clinically significant extent in the blood or liver. Over 200,000 patient treatments have been performed worldwide with the Contour I showing high patient satisfaction while demonstrating safety and efficacy. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guides the operator through a pres-determined treatment algorithm designed to minimize risk of contour irregularities, a common side effect of invasive and non-invasive procedures. The UltraShape procedure is performed during a convenient, 'walk-in, walk-out' session carried out in an office-based environment; it requires no anesthesia or sedation. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The Contour I system is not available for sale in the U.S; the Contour Plus system is an investigational product limited by U.S. law to investigational use only. | Health Technology |
Venus Concept Ltd.
Venus Concept Ltd. Medical SpecialtiesHealth Technology Venus Concept Ltd. provides procedural medical devices for aesthetic procedures. The firm specializes in advanced non-surgical platforms for body contouring, skin tightening, cellulite and scar reduction, skin resurfacing, skin rejuvenation, acne reduction, and hair removal. The company was founded by Domenic Serafino, Oded Ron-Edoute, and Orit Fishgold Ron-Edoute and is headquartered in Toronto, Canada. | Health Technology |
Venus Concept USA, Inc.
Venus Concept USA, Inc. Medical SpecialtiesHealth Technology Venus Concept USA, Inc. provides non-surgical aesthetic equipment to physicians and clinics for body contouring, skin tightening, and cellulite reduction. The company is headquartered in Weston, FL. | Health Technology |
Venus Concept Canada Corp.
Venus Concept Canada Corp. Medical SpecialtiesHealth Technology Venus Concept Canada Corp. provides medical and aesthetic technology equipment. The company is headquartered in Toronto, Canada. | Health Technology |
| NeoAsia Medical Group | |
Technicalbiomed Co., Ltd.
Technicalbiomed Co., Ltd. Medical DistributorsDistribution Services Technicalbiomed Co., Ltd. supplies medical equipment. The private company is based in Bangkok, Thailand. | Distribution Services |
